Baycol, a cholesterol-lowering prescription medication in the "statin" class, was withdrawn from the U.S. market in 2001 because of links to rhabdomyolysis, a severe adverse reaction involving muscle cell breakdown. This section contains health and legal information on Baycol (generic name cerivastatin).